Teva Pharmaceuticals, the largest generic drug manufacturer in the United States, has agreed to pay $450 million to resolve allegations of violating the False Claims Act and Anti-Kickback Statute arising from purported...more
10/16/2024
/ Anti-Kickback Statute ,
Co-payments ,
Criminal Penalties ,
Deferred Prosecution Agreements ,
Enforcement Actions ,
False Claims Act (FCA) ,
Healthcare Fraud ,
Kickbacks ,
Medicare ,
Medicare Part B ,
Medicare Part D ,
Patient Assistance Programs ,
Pharmaceutical Industry ,
Prescription Drugs ,
Price-Fixing ,
Private Foundations ,
Teva Pharmaceuticals